Skip to content

To Compare Dexamethasone And Fentanyl As An Adjuvant To 0.5% Bupivacaine And 2% Lignocaine In Supraclavicular Block Under Sonographic Guidance In Upper Extremity Surgeries

To Compare The Efficacy Of Dexamethasone And Fentanyl As An Adjuvant To 0.5% Bupivacaine And 2% Lignocaine In Supraclavicular Block Under Sonographic Guidance In Upper Extremity Surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034941
Enrollment
66
Registered
2021-07-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: USG GUIDED SUPRACLAVICULAR BLOCK: All patients will be kept fasting 8 hours prior to surgery. On arrival to the operating room NBM status and consent will be checked. Basic monitoring e

Sponsors

Shilpa Sarang Kore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I or II of either sex, Patients undergoing elective upper limb surgeries Haemodynamically stable patients with all routine investigations within normal limits Availability of informed consent.

Exclusion criteria

Exclusion criteria: Patient refusal Patients with ASA physical status III and more, Non cooperative patient Patients with nerve injury Patients who have known allergies to any test drugs. Patients with coagulation disorders or anti coagulant drugs, Patients with cardiac disease, Patients with respiratory diseases.

Design outcomes

Primary

MeasureTime frame
VAS Score for pain 0. Sensory blockade Motor blockade Duration of sensory blockade Duration of motor blockadeTimepoint: VAS Score for pain 0. Every 5 minutes from administration of block

Secondary

MeasureTime frame
duration of analgesiaTimepoint: 12 hours

Countries

India

Contacts

Public ContactDr SHILPA SARANG KORE

Dr DY Patil Medical College And Research Centre

shilpasale@gmail.com9767002436

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026